pH-activated phospholipase A2: An important mucosal barrier breaker in peptic ulcer disease

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 6, 2002, Pages 738-742

  Berstad, Audun E ^a   Berstad, K ^a   Berstad, A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE A2; PHOSPHOLIPASE A;

ACID SECRETION; BACTERIAL VIRULENCE; DIETARY INTAKE; ENZYME ACTIVATION; EPITHELIUM CELL; HELICOBACTER PYLORI; HOST RESISTANCE; HUMAN; NOTE; PEPTIC ULCER; PH; PRIORITY JOURNAL; STOMACH MUCOSA; ENZYMOLOGY; FEMALE; HELICOBACTER INFECTION; ISOLATION AND PURIFICATION; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; SECRETION; SENSITIVITY AND SPECIFICITY; STOMACH ACID;

FEMALE; GASTRIC ACID; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; HYDROGEN-ION CONCENTRATION; MALE; PEPTIC ULCER; PHOSPHOLIPASES A; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; HUMANS;

EID: 0035990188     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520212493     Document Type: Note

References (61)

1. Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease
2. Gastric mucus and the mucosal barrier
3. A novel method for the visualization of the in situ mucus layer in rat and man
4. Gastric surfactant and the hydrophobic mucosal barrier
5. Lysolecithin affects the viscosity, permeability, and peptic susceptibility of gastric mucin
6. Distribution of surfactants in the canine gastrointestinal tract and their ability to lubricate
7. Morphological effects of aspirin and prostaglandin on the canine gastric mucosal surface. Analysis with a phospholipid-selective cytochemical stain
8. Demonstration of a phospholipid-rich zone in the human gastric epithelium damaged by Helicobacter pylori
9. A physical identity for the gastric mucosal barrier
10. Mucus, pepsin, and peptic ulcer
11. Gastric mucus: Isolation and polymeric structure of the undegraded glycoprotein: Its breakdown by pepsin
12. The action of proteolytic enzymes on the glycoprotein from pig gastric mucus
13. Prostaglandin effect on the physical properties of gastric mucus glycoprotein and its susceptibility to pepsin
14. Properties of gastric and duodenal mucus: Effect of proteolysis, disulfide reduction, bile, acid, ethanol, and hypertonicity on mucus gel structure
15. Gastric mucosal barrier: Hydrophobic lining to the lumen of the stomach
16. Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: Insight into the mechanism and reversal of NSAID-induced gastrointestinal injury
17. Nonsteroidal anti-inflammatory drug and phospholipid prodrugs: Combination therapy with antisecretory agents in rats
18. Role of surface-active phospholipids in gastric cytoprotection
19. Gastric and duodenal ulcer
20. Milk and egg phospholipids act as protective surfactants against luminal acid in Necturus gastric mucosa
21. Surfactant approach to the gastric mucosal barrier: Protection of rats by banana even when acidified
22. 2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa
23. Lipolytic activity of Campylobacter pylori: Effect of sofalcone
24. Helicobacter pylori in vivo causes structural changes in the adherent gastric mucus layer but barrier thickness is not compromised
25. Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: Effect of clearance and eradication
26. Gastroduodenal mucus gel thickness in patients with Helicobacter pylori: A method for assessment of biopsy specimens
27. The adherent gastric antral and duodenal mucus gel layer thins with advancing age in subjects infected with Helicobacter pylori
28. Mucin exocytosis: A major target for Helicobacter pylori
29. Effect of Helicobacter pylori lipopolysaccharide on the synthesis of sulfated gastric mucin
30. The prevalence of Helicobacter pylori in peptic ulcer disease
31. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer
32. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study
33. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori
34. Prevention of ulcer recurrence after eradication of Helicobacter pylori: A prospective long-term follow-up study
35. Gastrin and acid in relation to Helicobacter pylori
36. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease
37. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal somatostatin receptor
38. Duodenal bulb acidity in patients with duodenal ulcer
39. Antroduodenal motility and movements of luminal contents studied by duplex sonography
40. Intestinal metaplasia, not atrophy or achlorhydria, creates a hostile environment for Helicobacter pylori
41. The role of Helicobacter pylori infection in the pathophysiology of duodenal ulcer disease
42. Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum
43. 2 activity in resting and activated human neutrophils. Substrate specificity, pH dependence, and subcellular localization
44. 2 activity in gastric juice from patients with active and Helicobacter pylori-eradicated healed duodenal ulcer
45. 2 activity in human gastric juice. With emphasis on Helicobacter pylori status and effects of antacids
46. 2 activity: A factor in peptic ulcer production?
47. 2
48. Potent ulcerogenic actions of platelet-activating factor on the stomach
49. Paf-acether synthesis by Helicobacter pylori
50. Characterization of Helicobacter pylori PldA, a phospholipase with a role in colonization of the gastric mucosa
51. Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies
52. Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases
53. A modified hemoglobin substrate method for the estimation of pepsin in gastric juice
54. Gastric mucosal barrier: Evidence for Helicobacter pylori ingesting gastric surfactant and deriving protection from it
55. Inactivation of human gastric pepsin by duodenal juice
56. Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently
57. The location of gastric ulcer
58. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole
59. A histological study of gastric mucosa before and after proximal gastric vagotomy in duodenal ulcer patients
60. Heticobacter pylori does not migrate from the antrum to the corpus in response to omeprazole
61. Gastric ulcer and antral border